Paving the way for innovative medicines
The Lead Discovery Center (LDC) was established in 2008 by the technology transfer organization Max Planck Innovation (MI), as a novel approach to capitalize on the potential of excellent basic research for the discovery of new therapies for diseases with high medical need. The LDC seeks to advance promising research projects into the development of novel medicines in a professional manner.
Efficient knowledge transfer from academia to industry
There is a great fundamental need for novel drugs. In order to respond to this need, the pharmaceutical industry is increasingly interested in innovative compounds that can become the basis for new drugs.
With a world-class team of interdisciplinary scientists, drug discovery experts, pharmacologists and seasoned project managers, the LDC offers the full scope of drug discovery support – from target to lead – according to the highest industry standards.
As an independent company with an entrepreneurial outlook, the LDC closely collaborates with research institutions, universities and industry. Our aim is to transform promising early-stage projects into innovative pharmaceutical leads that reach initial proof-of-concept in animals.